A recent paper by Devalingam Mahalingam, Professor of Medicine at Northwestern University Feinberg School of Medicine, was mentioned by ACS Journal Cancer on X:
“Open Access and available now.
This clinical trial of a P-cadherin-directed therapy proved unsuccessful, but valuable lessons are learned. Further investigation may yet achieve the therapeutic potential of targeting P-cadherin.
Read the study.”
Authors: Devalingam Mahalingam, Taofeek Owonikoko, Ebrahim Delpassand, Catherine Wheeler, Debra Richardson et al.
:
More posts featuring ACS Journal Cancer.
